The Journal. - The Wall Street Journal & Spotify Studios

Latest Episodes:

A 2020 Test Case Sep 09, 2019

Show notes

Voters are heading to the polls in North Carolina on Tuesday for a closely watched special election. How certain people vote may offer clues for how next year's presidential election could go.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Money's Role in College Admissions Sep 06, 2019

Show notes

Emails disclosed this week at the University of Southern California show how the school weighed donations in considering whether to admit students. Plus, the story of the SAT's "adversity score."

Learn more about your ad choices. Visit megaphone.fm/adchoices

A DNA Company Lets the FBI In Sep 05, 2019

Show notes

The inside story of how the founder of one of the first DNA-test companies, FamilyTreeDNA, wrestled with the choice to let the FBI use his company's database.

Learn more about your ad choices. Visit megaphone.fm/adchoices

What WeWork's Worth Sep 04, 2019

Show notes

Office-space startup WeWork was last valued at $47 billion. WSJ's Eliot Brown looks at the questions around WeWork's business model and CEO as it prepares to go public.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Jim Mattis: 'Right Up Front' With President Trump Sep 03, 2019

Show notes

In an interview with WSJ's Gerald Seib, former Defense Secretary Jim Mattis talks about his time working for President Trump, the threats facing the U.S. around the world, and what he'd like to see more of in American politics.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Why Every Day Isn't Payday Aug 30, 2019

Show notes

Many people in the U.S. get paid every two weeks. The question is: Why? And does it need to be that way? Banking reporter Telis Demos looks at how the two-week pay cycle came to be and a new push to change it.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Two Days of Reckoning for Opioid Makers Aug 28, 2019

Show notes

On Monday, a judge ordered Johnson and Johnson to pay Oklahoma $572 million for its role in the state's opioid crisis. And Tuesday, news broke that Purdue Pharma, the manufacturer of OxyContin, is in talks to resolve more than 2,000 opioid cases in a deal worth as much as $12 billion. WSJ's Sara Randazzo explains what the past two days mean for the fight to hold drugmakers legally accountable.

Learn more about your ad choices. Visit megaphone.fm/adchoices

If a Recession Hits, What's the Game Plan? Aug 26, 2019

Show notes

This summer, more worrying signs about the health of the American economy have emerged. WSJ's Jon Hilsenrath explains the tricky position the U.S. finds itself in if a slowdown arrives.

Learn more about your ad choices. Visit megaphone.fm/adchoices

The Dangerous Products on Amazon Aug 23, 2019

Show notes

A WSJ investigation has found that thousands of items offered by third-party sellers on Amazon have been declared unsafe, are deceptively labeled, or have been banned by federal regulators. Alexandra Berzon and Justin Scheck share the findings of their reporting.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Why Faster Internet Isn't Worth It Aug 21, 2019

Show notes

Broadband providers have marketed faster internet speeds for years, selling consumers on the promise that faster is better. The Wall Street Journal's Shalini Ramachandran and Thomas Gryta looked into whether that's actually the case.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Our TOPPODCAST Picks

Follow Us

Stay Connected

The Journal. – The Wall Street Journal & Spotify Studios

Related Podcasts

Links

Stay Connected